FI55503C - Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrimidinonderivat - Google Patents
Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrimidinonderivatInfo
- Publication number
- FI55503C FI55503C FI2825/72A FI282572A FI55503C FI 55503 C FI55503 C FI 55503C FI 2825/72 A FI2825/72 A FI 2825/72A FI 282572 A FI282572 A FI 282572A FI 55503 C FI55503 C FI 55503C
- Authority
- FI
- Finland
- Prior art keywords
- pyrimidinonderivat
- framework
- preparation
- therapeutic animal
- animal thermal
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI781204A FI55504C (fi) | 1971-10-29 | 1978-04-19 | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara hydroxi-pyrimidiner |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19400671A | 1971-10-29 | 1971-10-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI55503B FI55503B (fi) | 1979-04-30 |
| FI55503C true FI55503C (fi) | 1979-08-10 |
Family
ID=22715935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI2825/72A FI55503C (fi) | 1971-10-29 | 1972-10-12 | Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrimidinonderivat |
Country Status (25)
| Country | Link |
|---|---|
| JP (2) | JPS5337870B2 (en:Method) |
| AR (2) | AR198798A1 (en:Method) |
| AT (2) | AT321308B (en:Method) |
| AU (1) | AU467600B2 (en:Method) |
| BE (1) | BE790125A (en:Method) |
| CA (1) | CA980778A (en:Method) |
| CH (2) | CH555832A (en:Method) |
| DE (3) | DE2248741C3 (en:Method) |
| DK (1) | DK131465B (en:Method) |
| EG (1) | EG11013A (en:Method) |
| ES (2) | ES407730A1 (en:Method) |
| FI (1) | FI55503C (en:Method) |
| FR (1) | FR2157865B1 (en:Method) |
| GB (2) | GB1377720A (en:Method) |
| IE (1) | IE37043B1 (en:Method) |
| IL (2) | IL40458A (en:Method) |
| LU (1) | LU66304A1 (en:Method) |
| NL (1) | NL166470C (en:Method) |
| NO (1) | NO136574C (en:Method) |
| PH (2) | PH10129A (en:Method) |
| PL (2) | PL89852B1 (en:Method) |
| SE (2) | SE393376B (en:Method) |
| SU (2) | SU498908A3 (en:Method) |
| YU (2) | YU35125B (en:Method) |
| ZA (1) | ZA727362B (en:Method) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55151912U (en:Method) * | 1979-04-17 | 1980-11-01 | ||
| DE3222914A1 (de) * | 1982-06-18 | 1983-12-22 | Beiersdorf Ag, 2000 Hamburg | Substituierte 5-phenylthio-6-amino-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen |
| JPH0655686B2 (ja) * | 1988-08-30 | 1994-07-27 | 宇部興産株式会社 | ｐ−ブロモフェノキシアセトアルデヒドジアルキルアセタール類の製造方法 |
| CA2620065C (en) | 2005-08-22 | 2011-03-29 | Melior Discovery, Inc. | Methods and formulations for modulating lyn kinase activity and treating related disorders |
| US8552184B2 (en) | 2008-07-03 | 2013-10-08 | Melior Pharmaceuticals I, Inc. | Compounds and methods for treating disorders related to glucose metabolism |
| US20130158055A1 (en) | 2010-05-28 | 2013-06-20 | Andrew G. Reaume | Prevention Of Pancreatic Beta Cell Degeneration |
| EP3609500B1 (en) | 2017-04-10 | 2024-11-13 | Melior Pharmaceuticals I, Inc. | Treatment of adipocytes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2913462A (en) * | 1959-11-17 | Eahl h | ||
| GB951432A (en) * | 1959-03-17 | 1964-03-04 | Wellcome Found | Pyrimidine derivatives and the manufacture thereof |
-
0
- BE BE790125D patent/BE790125A/xx not_active IP Right Cessation
-
1972
- 1972-02-18 GB GB5005373A patent/GB1377720A/en not_active Expired
- 1972-02-18 GB GB774872A patent/GB1377308A/en not_active Expired
- 1972-09-25 SE SE7212358A patent/SE393376B/xx unknown
- 1972-09-28 IL IL40458A patent/IL40458A/en unknown
- 1972-09-28 AU AU47228/72A patent/AU467600B2/en not_active Expired
- 1972-10-02 PH PH13959A patent/PH10129A/en unknown
- 1972-10-05 DE DE2248741A patent/DE2248741C3/de not_active Expired
- 1972-10-05 DE DE2264374A patent/DE2264374C3/de not_active Expired
- 1972-10-05 DE DE2264657A patent/DE2264657C2/de not_active Expired
- 1972-10-06 AT AT858972A patent/AT321308B/de not_active IP Right Cessation
- 1972-10-06 AT AT00933/74A patent/AT320656B/de not_active IP Right Cessation
- 1972-10-12 FI FI2825/72A patent/FI55503C/fi active
- 1972-10-12 YU YU2551/72A patent/YU35125B/xx unknown
- 1972-10-13 NO NO3686/72A patent/NO136574C/no unknown
- 1972-10-13 SU SU1839308A patent/SU498908A3/ru active
- 1972-10-16 CH CH1507872A patent/CH555832A/fr not_active IP Right Cessation
- 1972-10-16 ZA ZA727362A patent/ZA727362B/xx unknown
- 1972-10-16 NL NL7213959.A patent/NL166470C/xx not_active IP Right Cessation
- 1972-10-16 PL PL1972174103A patent/PL89852B1/pl unknown
- 1972-10-16 DK DK510072AA patent/DK131465B/da not_active IP Right Cessation
- 1972-10-16 JP JP10279972A patent/JPS5337870B2/ja not_active Expired
- 1972-10-16 FR FR7236560A patent/FR2157865B1/fr not_active Expired
- 1972-10-16 PL PL1972158297A patent/PL84634B1/pl unknown
- 1972-10-16 CA CA153,956A patent/CA980778A/en not_active Expired
- 1972-10-16 LU LU66304A patent/LU66304A1/xx unknown
- 1972-10-16 CH CH165674A patent/CH549579A/fr not_active IP Right Cessation
- 1972-10-16 IE IE1398/72A patent/IE37043B1/xx unknown
- 1972-10-18 ES ES407730A patent/ES407730A1/es not_active Expired
- 1972-10-19 EG EG431/72A patent/EG11013A/xx active
- 1972-10-23 AR AR244763A patent/AR198798A1/es active
-
1973
- 1973-07-12 AR AR249053A patent/AR196263A1/es active
-
1974
- 1974-03-26 SU SU2008490A patent/SU505362A3/ru active
-
1975
- 1975-04-15 ES ES436624A patent/ES436624A1/es not_active Expired
- 1975-05-06 SE SE7505279A patent/SE397090B/xx unknown
- 1975-11-21 PH PH17784A patent/PH11594A/en unknown
-
1976
- 1976-01-05 IL IL48790A patent/IL48790A/en unknown
-
1978
- 1978-02-08 JP JP1336078A patent/JPS53116386A/ja active Granted
-
1979
- 1979-04-25 YU YU991/79A patent/YU36295B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE392269B (sv) | Forfarande for framstellning av vissa indanyloxitetrazoler | |
| SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
| SE400292B (sv) | Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat | |
| SE399701B (sv) | Forfarande for framstellning av hydroxyalkyldiamin | |
| SE394436B (sv) | Forfarande for framstellning av 7-halogen-linkomyciner | |
| FI54602B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 6-amidinopenicillansyraderivat | |
| FI55503C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrimidinonderivat | |
| SE417200B (sv) | Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat | |
| SE405478B (sv) | Forfarande for framstellning av alfa-sulfoacylcefalosporiner | |
| SE412756B (sv) | Alternativa forfarande for framstellning av 2-(aminofenylimino)-3-aza-1-tia-cykloalkaner | |
| SE385011B (sv) | Forfarande for framstellning av alfa-linkosaminider | |
| SE384686B (sv) | Forfarande for framstellning av linkomycinderivat | |
| SE408177B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat | |
| SE392902B (sv) | Forfarande for framstellning av fenylimidazolidinoner | |
| SE387936B (sv) | Forfarande for framstellning av substituerade metoxiaminer | |
| SE408418B (sv) | Forfarande for framstellning av 5-fluor-pyrimidiner | |
| SE380520B (sv) | Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin | |
| SE380795B (sv) | Forfarande for framstellning av tiokarbamider | |
| SE397350B (sv) | Forfarande for framstellning av tieno-diazepinderivat | |
| SE386897B (sv) | Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler | |
| SE387948B (sv) | Forfarande for framstellning av tiofen | |
| SE382046B (sv) | Forfarande for framstellning av 1-aryloxi-2-propanol | |
| SE407061B (sv) | Forfarande for framstellning av bensylpyrimidiner | |
| SE392724B (sv) | Forfarande for framstellning av 7-aminocefalosporansyra | |
| FI56171B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva asylerade piperidin-, tetrahydropyridin- och pyridinderivat |